Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibrutinib Maintenance in Mantle Cell Lymphoma
NCT02242097Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jan 2015
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibrutinib in mantle cell lymphoma (MCL), sponsored by Northwestern University. Started Jan 2015; status: completed.
02
Drugs
ibrutinib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02242097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242097.